These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38435107)

  • 1. Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells.
    Thaker SK; Shah PK; Das A; Maitra P
    Middle East Afr J Ophthalmol; 2023; 30(1):24-30. PubMed ID: 38435107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
    Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.
    Tomar AS; Finger PT; Gallie B; Kivelä T; Mallipatna A; Zhang C; Zhao J; Wilson M; Brennan R; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganeshan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef Y; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada GL; Schaiquevich P; Fandiño AC; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa Llano M; Carreras E; ;
    Br J Ophthalmol; 2023 Jan; 107(1):127-132. PubMed ID: 34340974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
    Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
    Ophthalmology; 2024 Oct; 131(10):1215-1224. PubMed ID: 38703794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitrectomy in eyes with unsuspected retinoblastoma.
    Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
    Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes).
    Kaliki S; Patel A; Iram S; Ramappa G; Mohamed A; Palkonda VAR
    Retina; 2019 Feb; 39(2):379-391. PubMed ID: 29210937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results.
    Bonanomi MTBC; de Almeida MTA; Hollaender MA; Bonanomi RC; Monteiro MLR
    Cancer Med; 2024 Feb; 13(3):e6683. PubMed ID: 38243643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
    Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
    Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETINOBLASTOMA ASSOCIATED WITH TOTAL EXUDATIVE RETINAL DETACHMENT: Treatment and Outcomes.
    Ghose N; Agarwal P; Palkonda VAR; Kaliki S
    Retina; 2023 May; 43(5):808-814. PubMed ID: 36728575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.
    Abramson DH; Ji X; Francis JH; Catalanotti F; Brodie SE; Habib L
    Br J Ophthalmol; 2019 Apr; 103(4):488-493. PubMed ID: 29875233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
    Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.